CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Mar 04, 2024 | Sale | $22.26 | 100,000 | 2,225,550 | 65,638 | Mar 06, 2024, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Feb 29, 2024 | Sale | $22.33 | 100,000 | 2,232,890 | 65,638 | Mar 04, 2024, 05:49 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Feb 07, 2024 | Sale | $41.54 | 2,506 | 104,110 | 15,638 | Feb 08, 2024, 07:14 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Nov 14, 2023 | Option Exercise | $14.31 | 45,648 | 653,339 | 25,528 | Nov 16, 2023, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Nov 07, 2023 | Option Exercise | $14.26 | 54,152 | 772,321 | 29,780 | Nov 09, 2023, 05:03 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Nov 08, 2023 | Option Exercise | $14.33 | 200 | 2,866 | 2,804 | Nov 09, 2023, 05:03 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Nov 03, 2023 | Option Exercise | $14.47 | 122,802 | 1,776,362 | 64,105 | Nov 06, 2023, 05:12 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Nov 02, 2023 | Sale | $14.34 | 77,198 | 1,107,336 | 41,303 | Nov 06, 2023, 05:12 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Sep 07, 2023 | Option Exercise | $13.78 | 100,000 | 1,378,415 | 52,704 | Sep 08, 2023, 04:35 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | Director | Jul 11, 2023 | Sale | $16.76 | 100,000 | 1,676,340 | 52,704 | Jul 13, 2023, 05:41 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Jun 01, 2023 | Sale | $18.05 | 100,000 | 1,805,070 | 52,704 | Jun 05, 2023, 08:12 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | May 04, 2023 | Sale | $17.48 | 100,000 | 1,748,434 | 52,704 | May 08, 2023, 04:24 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Apr 11, 2023 | Sale | $14.28 | 100,000 | 1,428,130 | 52,704 | Apr 13, 2023, 04:48 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Mar 02, 2023 | Sale | $15.31 | 94,000 | 1,438,877 | 49,704 | Mar 06, 2023, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Mar 03, 2023 | Sale | $15.35 | 6,000 | 92,070 | 5,704 | Mar 06, 2023, 04:15 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Feb 07, 2023 | Sale | $18.31 | 100,000 | 1,831,401 | 52,704 | Feb 08, 2023, 08:27 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Jan 05, 2023 | Sale | $16.72 | 100,000 | 1,671,871 | 52,704 | Jan 06, 2023, 05:04 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | COLES N ANTHONY | Director | Dec 28, 2022 | Sale | $578.17 | 11,516 | 6,658,232 | 6,851 | Dec 30, 2022, 04:10 PM |
CERE | | Cerevel Therapeutics Holdings, Inc. | COLES N ANTHONY | CEO and Chairperson | Dec 09, 2022 | Option Exercise | $15.08 | 100,000 | 1,508,300 | 52,704 | Dec 13, 2022, 04:44 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | COLES N ANTHONY | Director | Sep 06, 2022 | Sale | $476.84 | 12,000 | 5,722,084 | 6,793 | Sep 08, 2022, 04:06 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | COLES N ANTHONY | Director | Sep 15, 2021 | Sale | $512.48 | 23,896 | 12,246,291 | 12,850 | Sep 17, 2021, 04:01 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | COLES N ANTHONY | Director | Aug 17, 2021 | Sale | $497.74 | 1,800 | 895,923 | 1,802 | Aug 19, 2021, 04:04 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | COLES N ANTHONY | Director | Aug 18, 2021 | Sale | $497.74 | 10,200 | 5,076,897 | 6,002 | Aug 19, 2021, 04:04 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | COLES N ANTHONY | Director | Aug 13, 2021 | Sale | $485.24 | 4,000 | 1,940,940 | 2,902 | Aug 16, 2021, 04:04 PM |
REGN | | REGENERON PHARMACEUTICALS, INC. | COLES N ANTHONY | Director | Nov 13, 2020 | Option Exercise | $345.47 | 11 | 3,800 | 654 | Nov 13, 2020, 05:57 PM |
MCK | | MCKESSON CORP | COLES N ANTHONY | Director | Aug 17, 2020 | Sale | $156.77 | 2,453 | 384,559 | 0 | Aug 19, 2020, 03:35 PM |
MCK | | MCKESSON CORP | COLES N ANTHONY | Director | Aug 31, 2018 | Sale | $128.69 | 1,350 | 173,732 | 0 | Sep 04, 2018, 06:41 PM |
CRSP | | CRISPR Therapeutics AG | COLES N ANTHONY | Director | Oct 24, 2016 | Option Exercise | $14.00 | 35,000 | 490,000 | 70,000 | Oct 26, 2016, 06:28 PM |
CRSP | | CRISPR Therapeutics AG | COLES N ANTHONY | Director | Oct 24, 2016 | Option Exercise | $14.00 | 35,000 | 490,000 | 70,000 | Oct 26, 2016, 06:28 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | Chairman & CEO | Oct 01, 2013 | Option Exercise | $125.00 | 131,198 | 16,399,750 | 105,566 | Oct 03, 2013, 09:06 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | Chairman & CEO | Jun 05, 2013 | Sale | $62.59 | 13,124 | 821,431 | 137,760 | Jun 07, 2013, 06:49 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | Chairman & CEO | Apr 01, 2013 | Sale | $86.14 | 11,629 | 1,001,722 | 131,484 | Apr 03, 2013, 08:20 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | Chairman & CEO | Apr 03, 2013 | Option Exercise | $50.72 | 26,983 | 1,368,519 | 131,198 | Apr 03, 2013, 08:20 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | President & CEO | Oct 16, 2012 | Option Exercise | $30.96 | 125,599 | 3,888,295 | 233,942 | Oct 17, 2012, 06:27 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | President & CEO | Aug 08, 2012 | Sale | $51.46 | 520,690 | 26,795,904 | 379,033 | Aug 09, 2012, 05:17 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | President & CEO | Aug 01, 2012 | Sale | $74.37 | 8,820 | 655,943 | 154,033 | Aug 03, 2012, 07:29 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | President & CEO | Jul 25, 2012 | Sale | $73.97 | 11,883 | 879,007 | 162,853 | Jul 27, 2012, 08:20 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | President & CEO | Apr 02, 2012 | Option Exercise | $36.58 | 8,180 | 299,203 | 180,104 | Apr 03, 2012, 08:29 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | President & CEO | Jun 15, 2011 | Sale | $36.10 | 8,845 | 319,289 | 93,733 | Jun 17, 2011, 05:34 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | President & CEO | Apr 01, 2011 | Sale | $35.02 | 12,248 | 428,925 | 102,548 | Apr 04, 2011, 08:23 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | President & CEO | Dec 07, 2010 | Sale | $32.00 | 13,669 | 437,408 | 49,633 | Dec 08, 2010, 06:54 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | President & CEO | Aug 17, 2010 | Sale | $26.96 | 7,375 | 198,830 | 75,927 | Aug 19, 2010, 07:43 PM |
ONXX | | ONYX PHARMACEUTICALS INC | COLES N ANTHONY | President & CEO | Aug 19, 2010 | Sale | $26.08 | 12,625 | 329,211 | 63,302 | Aug 19, 2010, 07:43 PM |